Xianzhong Bai

Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

Aiping Zhou, Yuxian Bai, Yan Song et al. · The Oncologist · 2019 · 115 citations · Full text

Medicine, Oncology, Pharmacology +12

Interleukin-1α induces immunosuppression by mesenchymal stem cells promoting the growth of prostate cancer cells

Jiwen Cheng, Ling Li, Yan Liu et al. · Molecular Medicine Reports · 2012 · 48 citations · Full text

Life Sciences, Immunology, Oncology +17

Cystitis glandularis: A controversial premalignant lesion

Xianlin Yi, Haoyuan Lu, Yuexian Wu et al. · Oncology Letters · 2014 · 40 citations · Full text

Medicine, Oncology, Urology +9

Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial

Jianhui Ma, Yan Song, Jianzhong Shou et al. · Frontiers in Oncology · 2020 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

The enhanced expression of estrogen‐related receptor α in human bladder cancer tissues and the effects of estrogen‐related receptor α knockdown on bladder cancer cells

Xinqing Ye, Jinan Guo, Hongxiang Zhang et al. · Journal of Cellular Biochemistry · 2019 · 30 citations

Medicine, Molecular Biology, Oncology +17